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Abstract
Background: Stress cardiovascular magnetic resonance (CMR) perfusion imaging is a promising modality for the
evaluation of coronary artery disease (CAD) due to high spatial resolution and absence of radiation. Semi-quantitative
and quantitative analysis of CMR perfusion are based on signal-intensity curves produced during the first-pass of
gadolinium contrast. Multiple semi-quantitative and quantitative parameters have been introduced. Diagnostic
performance of these parameters varies extensively among studies and standardized protocols are lacking. This study
aims to determine the diagnostic accuracy of semi- quantitative and quantitative CMR perfusion parameters, compared
to multiple reference standards.
Method: Pubmed, WebOfScience, and Embase were systematically searched using predefined criteria (3272 articles). A
check for duplicates was performed (1967 articles). Eligibility and relevance of the articles was determined by two
reviewers using pre-defined criteria. The primary data extraction was performed independently by two researchers with
the use of a predefined template. Differences in extracted data were resolved by discussion between the two
researchers. The quality of the included studies was assessed using the ‘Quality Assessment of Diagnostic Accuracy
Studies Tool’ (QUADAS-2). True positives, false positives, true negatives, and false negatives were subtracted/calculated
from the articles. The principal summary measures used to assess diagnostic accuracy were sensitivity, specificity,
andarea under the receiver operating curve (AUC). Data was pooled according to analysis territory, reference standard
and perfusion parameter.
Results: Twenty-two articles were eligible based on the predefined study eligibility criteria. The pooled diagnostic
accuracy for segment-, territory- and patient-based analyses showed good diagnostic performance with sensitivity of 0.
88, 0.82, and 0.83, specificity of 0.72, 0.83, and 0.76 and AUC of 0.90, 0.84, and 0.87, respectively. In per territory analysis
our results show similar diagnostic accuracy comparing anatomical (AUC 0.86(0.83–0.89)) and functional reference
standards (AUC 0.88(0.84–0.90)). Only the per territory analysis sensitivity did not show significant heterogeneity. None
of the groups showed signs of publication bias.
Conclusions: The clinical value of semi-quantitative and quantitative CMR perfusion analysis remains uncertain due to
extensive inter-study heterogeneity and large differences in CMR perfusion acquisition protocols, reference standards,
and methods of assessment of myocardial perfusion parameters. For wide spread implementation, standardization of
CMR perfusion techniques is essential.
Trial registration: CRD42016040176.
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Background
In recent years it has become apparent that information on
the functional consequence of a stenosis in the coronary ar-
teries is essential in prognostication and treatment of pa-
tients with coronary artery disease (CAD) [1–3]. Invasive
coronary angiography is the current gold standard for the
assessment of CAD according to the ESC guidelines [4, 5].
Fractional flow reserve (FFR) measurements are used to as-
sess the functional significance by determining the pressure
drop over an epicardial stenosis [6]. The disadvantage of
invasive coronary angiography is that it is an invasive pro-
cedure, exposing patients to procedural risks and radiation
[7–11]. In addition, in up to 60% of the patients undergoing
invasive angiography, no significant stenosis is present sug-
gesting that the pre-selection of patients for invasive coron-
ary angiography can be improved [12].
A variety of noninvasive imaging modalities exists which
show potential to be used in the (functional) assessment
of patients suspected of CAD. These modalities include
positron emission tomography (PET), cardiovascular mag-
netic resonance (CMR), computed tomography (CT), and
single-photon emission computed tomography (SPECT).
The different myocardial perfusion imaging (MPI) modal-
ities all show a high diagnostic accuracy with an area
under the curve (AUC) of 0.95 (0.91–0.99) for CMR per-
fusion imaging in general compared to 0.93 for PET, 0.93
for CT, and 0.82 for SPECT, respectively [13]. A disadvan-
tage of MPI performed with either PET, SPECT or CT is
the radiation exposure during the examination [11, 14].
MPI by stress CMR perfusion combines a high spatial
resolution with the absence of radiation. These features
make CMR perfusion an interesting modality for routine
clinical assessment of CAD. The diagnostic accuracy of
CMR perfusion imaging has been assessed in multiple
studies and recent meta-analyses have provided exten-
sive overviews of available evidence [13, 15–18], however
these meta-analyses do not discriminate between quali-
tative and quantitative assessment. Currently, the visual
assessment of perfusion defects is used in clinical prac-
tice [19].Visual assessment however, is subjective and
highly dependent on expertise. However, analysis of the
signal-intensity curves (SI-curves) that can be acquired
during the first wash-in of the paramagnetic contrast
agent gadolinium have potential to provide quantitative
information on myocardial perfusion. These SI-curves to
evaluate the myocardial blood flow (MBF) can be evalu-
ated by semi-quantitative or quantitative methods [20].
The semi-quantitative method is based on the maximal
upslope of the tissue attenuation curve (TAC) [21]. The
quantitative method is based on model dependent de-
convolution using the SI-curves. A variety of tracer kin-
etic models are used providing a MBF value related to
the physiological MBF [22]. There are various proposed
models for model dependent deconvolution with varying
complexity. Both the semi-quantitative and quantitative
parameters can be analyzed relatively as a ratio between
values during stress and rest MPI or as absolute values.
Although a large number of studies have been per-
formed, meta-analysis of CMR perfusion available to
date did not evaluate the diagnostic performance of
these semi-quantitative and quantitative analysis of the
SI-curves acquired during the first-pass perfusion.
Therefore, the aim of this meta-analysis was to assess
the diagnostic accuracy of semi-quantitative or quantita-
tive CMR perfusion imaging analysis based on SI time
(SI-curves) as compared to either anatomical(quantita-
tive coronary angiography (QCA)) or functional refer-
ence standards (invasive coronary angiography +/− FFR)
in patients with suspected or known CAD.
Methods
Protocol and registration
This meta-analysis was performed in concordance with
the Preferred Reporting Items for Systematic Reviews
and Meta-analyses (PRISMA) statement and was regis-




To produce an extensive overview of the diagnostic accur-
acy of both semi-quantitative and quantitative CMR perfu-
sion analysis, the following criteria to determine eligibility
where used: study domain – patients with known or sus-
pected CAD. Index test – quantitative or semi-quantitative
CMR perfusion. Reference standard – invasive coronary
angiography +/− FFR and QCA. Study results – diagnostic
accuracy of index test compared to reference standard.
Study design – observational. Overlap in study population
between studies was corrected for by only including the
study with the highest number of patients. Studies evaluat-
ing visual CMR perfusion outcome measures not based on
time intensity curves, evaluation on a segmental basis, ani-
mal studies, phantom studies, and dose ranging studies
were excluded from both the qualitative and quantitative
analysis. Furthermore, reviews and overview documents
were excluded from the quantitative analysis.
Search strategy
The following search strategy was used in Pubmed:
(“Myocardial Ischemia”[Mesh] OR myocardial OR cardiac
OR “coronary artery”) AND (“Magnetic Resonance Imagi-
ng”[Mesh] OR Magnetic Resonance[tiab] OR mri[tiab]
OR MRP[tiab]) AND (“Perfusion Imaging”[Mesh] OR per-
fusion[tiab]) AND (Quantification*[tiab] OR quantitative[-
tiab] OR deconvolut*[tiab] OR myocardial perfusion
reserve[tiab] OR mpr[tiab] OR semiquantitative [tiab] OR
semiquantitative [tiab] OR semiquantitative OR MPRI
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[tiab] OR myocardial blood flow [tiab] OR MBF [tiab] OR
contrast enhancement ratio [tiab] OR left ventricular up-
slope [tiab] OR upslope integral [tiab] OR CER [tiab] OR
SLP [tiab] OR INT [tiab]). Additionally, Embase and Web
of Science were searched using adjusted search strategy to
fit the search matrix of the source.
Study selection
The search strategy was set-up in collaboration with the
local Medical Library (Central Medical Library University
Medical Center Groningen). One researcher (RvD) exe-
cuted the search and gathered the results in Mendeley
(version 1.16.1). A check for duplicates was performed
with both the built in ‘check for duplicates’ function as well
as manually (RvD). Screening for study eligibility and rele-
vance of the articles retrieved by the search strategy was
performed individually by two reviewers (RvD and MvA)
using the pre-defined study eligibility criteria. Studies were
categorized as includable, possibly includable, non-
includable by screening the titles and abstracts. Inter-
reviewer categorization was compared and in case of dis-
agreement discussed to obtain consensus.
Data collection process
The primary data extraction was performed independently
by both researchers (RvD and MvA) with the use of a prede-
fined template. Data extraction was cross checked and dis-
cussed to achieve consensus. In case of missing or unclear
data the corresponding authors were contacted (n = 12), in
absence of a response the studies were excluded.
Data items
The following patient characteristics were collected:
age, gender, prevalence of CAD, and coronary artery
disease risk factors. Data on study design was col-
lected, including: prospective/retrospective set up,
number of patients enrolled, number of patients ex-
cluded, scanner type and manufacturer, stressor agent
and dose, contrast agent, perfusion sequence, cardiac
segmentation method, reference standard, outcome
measures with reported sensitivity, specificity, negative
predictive value, positive predictive. The number of
true positives (TP), false positives (FP), true negatives
(TN), and false negatives (FN) were derived directly
from the article or calculated from the sensitivity and
specificity reported in the articles. All the figures and
tables in this article are original for this article.
Quality assessment
Two reviewers (RvD and MvA) independently evaluated
the study quality of the included studies using the ‘Qual-
ity Assessment of Diagnostic Accuracy Studies Tool’
(QUADAS-2) [23]. Risk of bias was assessed across all
studies and within each individual study using RevMan
software (version 5.3.5, Cochrane collaboration).
Statistical analysis
The principal summary measures used to assess diag-
nostic accuracy were sensitivity, specificity, Diagnostic
Odds Ratio (DOR), and AUC. In case studies performed
multiple semi-quantitative or quantitative analyses we
chose the maximal upslope parameter as a representa-
tive measure for semi-quantitative analysis and absolute
MBF for quantitative analysis. Furthermore, transmural
ratios were used when studies reported sub-endocardial,
sub-epicardial, and transmural outcomes. When multiple
tracer kinetic models were used for quantitative analysis,
the Fermi model was selected. When both a semi-
quantitative and a quantitative outcome, or both 1.5 T as
well as 3.0 T were used, both outcomes were taken into
account for the analysis.
The primary data synthesis was based on bivariate
mixed-effects binary regression modeling. Sensitivity,
specificity, and heterogeneity (using the Q-statistic and
I2 index) were calculated and displayed in forest plots.
Significant heterogeneity was defined as Q-statistic
p < 0.10 and/or I2 > 50%. Separate subgroup forest plots
were evaluated when >5 studies were available.
The Deeks’ funnel test was used to test for publication
bias, with a value <0.05 indicative of publication bias or
systematic difference between results of larger and
smaller studies. The DORs were used to calculate the
summary receiver operating curves (sROC). Based on
the ROC curves the AUC was calculated. Data analysis
was performed with STATA (version 13.0; STATA cor-
poration, Lakeway Drive, College Station, Texas, USA).
Results
The systematic search in Pubmed, WebOfScience, and
Embase identified 3272 articles. After the removal of du-
plicates, 1967 articles were screened based on title and
abstract. The resulting 137 articles were assessed in full
text for eligibility. Of these, 23 articles were deemed eli-
gible based on the predefined study eligibility criteria in-
cluding a total of patients, with mean age ranging from
57 to 67 years. The PRISMA flowchart is shown in Fig. 1.
The final analysis included 22 articles due to exclusion
of one study using dobutamine as a stressor agent in
which an inadequate heart rate response for diagnosis
was achieved in most age groups.
Studies were performed at 1.5 T in 20 (91%) studies and
at 3 T in 6 (27%) studies (Bernhardt et al. used both 1.5 T
as well as 3.0 T). The stressor agent used was either ad-
enosine or dipyridamole in 18 (82%) and 6 (27%), studies,
respectively. Segment based outcome data was available in
4 (18%) of all studies, territory based outcome data was
available in 13 (59%) and patient based outcome data in
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11 (50%) studies included (Bertschinger et al. and Papa-
nastasiou et al. reported both territory and patient based
data). Perfusion analysis was performed semi-quantitative
in 16 (73%) studies and quantitative in 10 (45%) (Huber et
al. and Mordini et al. reported data on both semi-
quantitative and quantitative analysis). The reference
standard was anatomical in 15 (68%) studies and func-
tional in 11 (50%). See Tables 1, 2 and 3.
Diagnostic performance
Four studies with per segment-based analysis could be
included, all using an anatomical reference method
(QCA). Segment-based pooled sensitivity, specificity,
and DOR were 0.88 (95% CI, 0.82–0.93), 0.72 (95%CI,
0.56–0.84), and 19 (95% CI, 9–40), respectively. ROC
curve analysis showed an AUC of 0.90 (95% CI, 0.87–
0.92). See Table 4 and Figs. 2 and 3.
Eleven studies were included analyzing the perfusion
data on a per territory basis with Huber et al. [24]
reporting on both semi-quantitative and quantitative
analysis, including twelve study outcomes in the final
per territory analysis. Territory-based pooled sensitivity,
specificity, and DOR were 0.82 (95% CI, 0.77–0.86), 0.83
(95% CI, 0.74–0.90), and 21 (95% CI, 10–45), respectively.
ROC curve analysis showed an AUC of 0.84 (95% CI,
0.81–0.87). See Table 4 and Figs. 4 and 5. Quantitative
analysis (n = 6) on a per territory base yielded a sensitivity,
specificity, and DOR of 0.77 (95% CI, 0.62–0.87), 0.86
(95% CI, 0.72–0.94), and 21 (95% CI, 6–8) with an AUC of
0.88 (95% CI, 0.85–0.91), while semi-quantitative analysis
(n = 6) yielded a sensitivity and specificity of 0.77 (95% CI,
0.60–0.88) and 0.84 (95% CI, 0.76–0.89) with an AUC of
0.87 (95% CI, 0.84–0.90). Using a functional reference
(n = 7) standard yielded a sensitivity, specificity, and DOR
of 0.77 (95% CI, 0.63–0.86), 0.85 (95% CI, 0.73–0.92), and
18 (95% CI, 6–59) with an AUC of 0.88 (95% CI, 0.84–
0.90), while the use of an anatomical reference (n = 5)
showed sensitivity, specificity, and DOR of 0.85 (95% CI
0.78–0.90), 0.83 (95% CI, 0.72–0.91), and 28 (95% CI, 13–
63) with an AUC of 0.86 (95% CI, 0.83–0.89).
Eight studies were included analyzing the CMR perfu-
sion data on a per patient basis, of which Mordini et al.
[20] reported on both semi-quantitative and quantita-
tive outcome and Bernhardt et al. [25] performed ana-
lysis at both 1.5 T and 3.0 T, in the end including ten
study outcomes in the final per patient analysis. Six had
Fig. 1 Flow diagram of the literature search and selection of relevant studies
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an anatomical reference standard and 4 a functional
reference standard. Patient based sensitivity, specificity,
and DOR were 0.83 (95% CI, 0.75–0.88), 0.76 (95% CI,
0.65–0.85), and 15 (95%CI 6–36). ROC curve analysis
showed an AUC of 0.87 (95% CI, 0.84–0.90). See Table 4
and Figs. 6 and 7.
Diagnostic accuracy in patients with decreased left
ventricular ejection fraction or multi-vessel disease
The study of Krittayaphong et al. reported on the diag-
nostic accuracy of MPRI in patients with decreased left
ventrticular ejection fraction (LVEF). They report a de-
creased sensitivity, specificity and diagnostic accuracy in
the subgroup of patients with decreased LVEF (sensitiv-
ity 88.9%, specificity 58.3% and diagnostic accuracy 71.5)
as compared to patients with normal LVEF (sensitivity
89.7%, specificity 93.8% and diagnostic accuracy 91.1).
Mordini et al. report that all their patients with multi-
vessel disease (n = 7) were correctly identified with
quantitative perfusion analysis. Giang et al. present a
similar sensitivity and specificity whether patients with
three vessel disease were included or not across all
tested doses (e.g. 94/71% sensitivity/specificity when pa-
tients with three vessel disease included at dose 3 com-
pared to a 91%/71% sensitivity/specificity when patients
with three vessel disease excluded).

















34 32 59+/−11 NS NS NS NS NS 100 NS
Bertschinger
2001 [28]
14 NS NS NS NS NS NS NS 93 NS
Ibrahim 2002 [29] 25 19 63+/−13 NS 28 NS 68 56 100 12
Nagel 2003 [30] 84 73 63+/−8 0 0 21 NS NS 51 0
Giang 2004 [31] 29 25 58+/−8 45 14 34 59 52 66 38
Plein 2005 [32] 92 68 58+/−11 30 8 35 54 NS 64 19
Rieber 2006 [33] 43 38 66+/−8 86 23 35 NS 28 67 19
Positano 2006
[34]
32 20 65+/−10 NS NS NS NS NS 50 NS
























40 27 62+/−7 49 15 29 41 NS 34 NS




34 26 62+/−11 80 15 47 53 NS 62 NS
Huber 2012 [24] 23 27 67+/−12 36 23 85 29 NS 55 19
Motwani 2012
[40]
40 27 64+/−8 NS NS NS NS NS 53 NS
Chiribiri 2013 [41] 30 22 59+/−11 NS 27 27 NS NS 80 NS
Mordini 2014 [20] 67 45 60+/−11 60 16 42 75 25 34 25
Motwani 2014
[42]
35 26 62+/−8 51 17 40 54 9 57 9
Yun 2015 [43] 58 17 60+/−11 59 26 28 48 10 31 16
Pan 2015 [44] 71 57 60+/−6 8 31 61 62 9 55 NS
Papanastasiou
2016 [45]
24 20 63 ± 7 13 3 6 NS 4 67 7
aAge either mean+/−SD or mean(range). HT hypertension, DM diabetes mellitus, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, CAD
Coronary Artery Disease, MI myocardial infarct
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Study quality assessment and publication bias
The overall methodological quality of the studies
was good See Figs. 8 and 9. The per territory ana-
lysis pooled sensitivity, per territory anatomical ref-
erence standard sensitivity and per territory semi-
quantitative specificity did not show significant het-
erogeneity See Figs. 2, 4, 6 and Table 4. The Deeks’
Funnel plots did not indicate publication bias or sys-
tematic difference between results of larger and
smaller studies See Figs. 10 and 11.
Table 2 Overview of the study specific acquisition protocol





Al-Saadi 2000 [27] 1.5 T,
Philips
Rest/stress Dipyridamole Gadopentate (Magnevist) 0.025 mmol/kg T1-weighted inversion recovery
single-shot turbo gradient echo
Bertschinger 2001 [28] 1.5 T, G.E. Stress only Dipyridamole Gadodiamide (Omniscan) NS interleaved gradient-echo EPI
Ibrahim 2002 [29] 1.5 T,
Phillips
Rest/stress Adenosine Gadopentate (Magnevist) 0.05 mmol/l A fast hybrid, gated-imaging se-
quence consisting of three short-
axis slices was used




0.025 mmol/kg single shot segmented k-space
turbo-gradient-echo/echo-planar-
imaging (EPI)-hybrid
Giang 2004 [31] 1.5 T, G.E. Stress only Adenosine Gadopentate (Magnevist) 0.05 mmol/kg hybrid echo planar
Plein 2005 [32] 1.5 T,
Philips
Rest/stress Adenosine Gadopentate (Magnevist) 0.05 mmol/kg dynamic segmented k-space
gradient-echo combined with
SENSE
Rieber 2006 [33] 1.5 T,
Siemens
Stress/rest Adenosine Gadodiamide (Omniscan) 0.05 mmol/kg T1-weighted saturation recovery
turbo flash
Positano 2006 [34] 1.5 G.E. Rest/stress Dipyridamole Gadodiamide (Omniscan) 0.1 mmol/kg fast gradient-echo train
Costa 2007 [35] 1.5
Siemens
Stress/rest Adenosine Gadolinium (Magnevist) 0.1 mmol/kg single-shot gradient-echo
Pignitore 2008 [36] 1.5 G.E. Rest/stress Dipyridamole Gadodiamide (Omniscan) 0.1 mmol/kg fast gradient-echo train
KrittayaPhong 2009 [37] 1.5 T,
Phillips
Stress/rest adenosine Gadopentate (Magnevist) 0.05 mmol/l ECG-triggered, T1 weighted,
inversion receovery single shot
turbo gradient echo sequence
Kirschbaum 2011 [38] 1.5 T, GE
Medical
Systems
Rest/stress adenosine Gadopentate (Magnevist) 0.05 mmol/kg steady state free-precession
technique
Lockie 2011 [39] 3.0 T,
Philips
Stress/rest Adenosine Gadopentate (Magnevist) 0.05 mmol/kg saturation recovery gradient echo
method
Bernhardt 2012 [25] 1.5 T/
3.0 T,
Philips
Stress/rest Adenosine Gadoterate meglumine
(Dotarem)
0.075 mmol/kg steady state free-precession
technique
Huber 2012 [24] 1.5 T,
Siemens
NS Adenosine Gadopentate (Magnevist) 0.05 mmol/kg saturation turboFlash
Motwani 2012 [40] 3.0
Phillips
Stress/rest Adenosine Gadopentate (Magnevist) 0.05 mmol/kg Saturation-recovery gradient echo
Chiribiri 2013 [41] 3.0 T,
Philips
Stress/rest Adenosine Gadopentate (Magnevist) 0.05 mmol/kg saturation-recovery gradient echo
Mordini 2014 [20] 1.5 T,
Siemens
Stress/rest Dipyridamole Gadopentate (Magnevist) 0.005 mmol/kg
followed by
0.1 mmol/kg
saturation recovery hybrid echo-
planar
Motwani 2014 [42] 3.0 T,
Philips
Stress/rest Adenosine Gadobutrol (Gadovist) 0.075 mmol/kg 3D spoiled turbo gradient-echo
Yun 2015 [43] 3.0 T,
Philips
Stress/rest Dipyridamole Gadobenate Dimeglumine
(Multihance)
0.05 mmol/kg saturation recovery gradient-echo
T1-weighted
Pan 2015 [44] 3.0 T,
Siemens
Stress/rest Adenosine Gadobutrol (Gadovist) 0.075 mmol/kg T1-weighted saturation recovery
turbo flash
Papanastasiou 2016 [45] 3.0 T,
Siemens
Stress/rest Adenosine Gadobutrol (Gadovist) 0.05 mmol/kg Turbo-fast low saturation recovery
single-shot gradient echo
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Discussion
Summary of evidence
The pooled diagnostic accuracy for segment-, territory- and
patient-based analyses showed good diagnostic perform-
ance. The diagnostic accuracy of CMR perfusion analysis
has been assessed in previous meta-analyses [13, 15–18].
However, this meta-analysis is the first focusing on the
semi-quantitative and quantitative analysis of the SI-curves.
The diagnostic accuracy of CMR perfusion (pooled for vis-
ual, semi-quantitative, and quantitative analysis) reported in
the earlier meta-analyses range from AUC 0.90 to 0.94 [13,
15–18]. When comparing our results, the SI-curve based
Table 3 Overview of study specific cardiac segmentation method, data interpretation, reference standard, cut-off values for significant









6 segments (mid ventricular) Territory QCA ≥75% DS Semi-quantitative
Bertschinger
2001 [28]
4 × 8 segments Patient/
Territory
QCA ≥50% stenosis Semi-quantitative
Ibrahim 2002
[29]
3 short axis slices 18 segments per slice/polar
maps subdivided into 6 segments
Territory QCA >75% DS Semi-quantitative
Nagel 2003
[30]
5 short axis slices 6 segments per slice Patient Visual ICA ≥75% DS Quantitative
Giang 2004
[31]
3 × 8 segments good quality score Patient QCA ≥50% DS Semi-quantitative
Plein 2005 [32] 16 segments (AHA) Patient Visual ICA >70% DS Quantitative
Rieber 2006
[33]
16 segments (AHA) Territory QCA + FFR >50% DS on QCA and FFR ≤0.75 Semi-quantitative
Positano 2006
[34]
3 short axis slices 16 segments Segment QCA ≥75% DS Semi-quantitative
Costa 2007
[35]
3 short axis 8 segments per slice Segment QCA >70% DS Quantitaive
Pignitore 2008
[36]
3 short axis slices 16 segments Segment QCA ≥50% DS Semi-quantitative
KrittayaPhong
2009 [37]
16 segments (AHA) Patient Visual ICA ≥50% Semi-quantitative
Kirschbaum
2011 [38]
16 segments (AHA) Patient ICA with
CFR
CFR < 2.0 Semi-quantitative
Lockie 2011
[39]
16 segments (AHA) Territory FFR <0.75 Quantitative
Bernhardt
2012 [25]
16 segments (AHA) Patient FFR ≤0.80 Semi-quantitative
Huber 2012
[24]
18 segments (6 per slice) Territory QCA + FFR >75% DS on QCA or 51 - 75% DS






1 midventricular slice 6 segments Segment QCA >70% DS Quantitative
Chiribiri 2013
[41]
16 segments (AHA) Territory FFR <0.80 Quantitative
Mordini 2014
[20]





Whole heart Territory QCA ≥75% DS Quantitative
Yun 2015 [43] 16 segments (AHA) Territory QCA >70% DS Semi-quantitative
Pan 2015 [44] 16 segments (AHA) (mean of 2 lowest value
assigned to coronary territories)
Territory FFR ≤0.75 Quantitative
Papanastasiou
2016 [45]
16 segments (AHA) Patient/
Territory
ICA + FFR ≥70% DS on ICA or FFR <0.80
and luminal stenosis ≥50%
Quantitative
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Table 4 Pooled diagnostic accuracy of semi-quantitative and quantitative CMR perfusion analysis on segmental, territory, and per







































































































aQ statistic p-value <0.10 and/or bI2 > 50% is considered to indicate heterogeneity. Subgroup analysis was performed when ≥5 studies were available
Fig. 2 Forest plot of per segment sensitivity and specificity of both semi-quantitative and quantitative CMR perfusion analysis against anatomical
and functional reference standards. Significant heterogeneity was defined as Q-statistic p < 0.10 and/or I2 > 50%
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analysis of CMR perfusion does not lead to an increase in
the diagnostic accuracy as compared to the combined diag-
nostic accuracy of CMR perfusion as reported in these pre-
vious papers. Visual analysis of CMR perfusion does not
yield lower diagnostic accuracy. This is possibly due to the
fact that visual observations are made upon fewer and less
complex assumptions than both the semi-quantitative and
quantitative analysis methods that are used. Both semi-
quantitative and quantitative perfusion analysis are based
on SI-curves and calculate a derivative of myocardial blood
flow based on certain assumptions. The models used for
quantitative analysis are mathematical representations of a
physiological process and rely on assumptions made about
the dynamic of contrast and blood plasma and pre-existing
knowledge about the physiologic process and model dy-
namics. In these models it is assumed that there is no diffu-
sion of contrast medium into the intracellular space.
Unfortunately, only in a few specific contrast agents this is
the case. Different models are used for CMR perfusion ana-
lysis, with different degrees of complexity, and the optimal
model is yet to be determined. The complexity of this mod-
eling process, the many assumptions made and thereby the
selection of a suitable model makes model-dependent per-
fusion analysis highly susceptible to error and with incon-
sistent results as a consequence. The use of different
models with varying results could add to the heterogeneity
in the quantitative analysis group. Semi-quantitative ana-
lysis, although in theory inferior to quantitative analysis, is
a relatively simple method to estimate perfusion. The low
complexity of these methods make it a robust method,
allowing for less variation among research groups. As visual
CMR perfusion analysis is relatively simple as compared to
either semi-quantitative and/or quantitative CMR perfusion
analysis, it is possible that this method is less susceptible to
methodological errors (causing false conclusions). However,
the methods used for assessing semi-quantitative CMR per-
fusion also vary within studies. The large variation in both
semi-quantitative and quantitative CMR perfusion post
processing techniques make it challenging to make an
accurate comparison due to extensive inter-study hetero-
geneity. We compared the diagnostic accuracy of semi-
quantitative and quantitative CMR perfusion analysis on a
per territory basis and observed that the diagnostic accur-
acy slightly decreased using quantitative analysis (AUC of
0.87(0.83–0.89) compared to 0.81(0.78–0.85)). This is pos-
sibly due to the fact that quantitative analysis is based on
multiple assumptions.
If the noninvasive MPI techniques are to be used as a
gatekeeper for further diagnosis and treatment it is im-
portant to select a modality in which the amount of false
negative results is low to assure that patients with sig-
nificant disease are not missed. This requires the sensi-
tivity of the gatekeeper test to be high. We were also
performed subgroup analyses in the per territory group,
based on the reference standards used. The anatomical
reference standards merely depict the presence or
absence of epicardial coronary stenosis (visual invasive
coronary angiography, QCA), whereas the functional ref-
erence standards contained functional information on ei-
ther pressure drop across the stenosis (FFR).
Our results show similar diagnostic accuracy when
anatomical reference standards were used (0.85(0.82–
0.88)) as compared to the diagnostic accuracy of SI-
curve analysis with the use of functional reference
standards (0.82(0.79–0.86)) in the per territory analysis.
For the anatomical reference standard, a DS >50, >70%
or >75% were generally used as the cut-off value for sig-
nificant CAD in both QCA and visual angiographic as-
sessment. For the functional reference standard, a FFR
of either <0.75 or <0.8 were used to indicate significant
CAD. The accuracy of the anatomical reference stan-
dards as well as the currently used gold standard for
functional reference of invasive coronary angiography
+/− FFR for determining flow limiting CAD are debat-
able. Furthermore, pooling of the different threshold also
increases heterogeneity in this meta-analysis. Previous
research has shown that the anatomical presence of a
stenosis, with cut-off values of either >50% DS or >70%
DS have a poor correlation with FFR [1]. The use of the
functional FFR measurement to guide therapy has
proven to be superior as compared to anatomical assess-
ment alone [2]. The FFR measurement is based on the
measurement of a pressure drop across an epicardial
vessel pre- and post-stenosis and a value of either <0.75
Fig. 3 Summary receiver operating curve of the diagnostic
performance of segmental semi-quantitative and quantitative CMR
perfusion analysis
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or a more liberal cut-off of <0.8 is used to indicate a
functionally significant epicardial stenosis. However,
what both the anatomical reference standard and the
functional FFR measurement ignore microvasculature
perfusion defects and the assumptions of a linear rela-
tionship between increasing stenosis or decreasing pres-
sure with decreasing flow is made. To better understand
the myocardial perfusion, van de Hoef et al. aimed to de-
termine the relationship between invasively measured
FFR and coronary flow reserve. The results of this study
indicate a non-linear relationship between FFR (pressure
drop information) and coronary flow reserve (flow infor-
mation). The authors conclude that the disagreement
between FFR and coronary flow reserve is caused by the
involvement of the microvasculature and this indicates
that the functional FFR measurement is not an accurate
representation of myocardial perfusion [26]. We believe
that there is a trend towards a better understanding
of the complex process of myocardial perfusion and
that the currently used reference standard as of yet
fail to accurately represent myocardial perfusion. The
need for a well validated and robust measurement
technique for measuring myocardial perfusion is ne-
cessary and this technique might be used in the
SENSITIVITY (95% CI)
Q = 10.45, df = 11.00, 
p =  0.40
I2 = 0.00 [0.00 − 87.51]
 0.82[0.77 − 0.86]
0.90 [0.79 − 0.96]
0.81 [0.58 − 0.95]
0.71 [0.42 − 0.92]
0.85 [0.55 − 0.98]
0.79 [0.58 − 0.93]
0.92 [0.62 − 1.00]
0.75 [0.43 − 0.95]
0.79 [0.62 − 0.91]
0.84 [0.69 − 0.94]
0.83 [0.59 − 0.96]
0.80 [0.67 − 0.90]
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Fig. 4 Forest plot of per territory sensitivity and specificity of both semi-quantitative and quantitative perfusion analysis against anatomical and
functional reference standards. Significant heterogeneity was defined as Q-statistic p < 0.10 and/or I2 > 50%
Fig. 5 Summary receiver operating curve of the diagnostic performance
of territory based semi-quantitative and quantitative CMR perfusion analysis
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future as the gold standard. The inability of both the
anatomical and functional reference standards to ac-
curately represent myocardial blood flow might have
influenced the results and so the results of this meta-
analysis should be interpreted with caution.
Further research is necessary to determine the ideal
golden standard for myocardial perfusion. We emphasize
that it might be beneficial to first critically review phan-
tom or ex-vivo research regarding the determination of
myocardial perfusion in search for the measurement
which represents true myocardial blood flow as accur-
ately as possible.
In our meta-analysis we found an extensive vari-
ation in study population, CMR protocols, post pro-
cessing techniques, and reference standards used.
The lack of standardized CMR perfusion protocols
or post processing techniques might have influenced
our estimates of a lower diagnostic accuracy than ex-
pected of semi-quantitative and quantitative CMR
perfusion analysis as compared to visual assessment.
The extensive heterogeneity between the study pro-
tocols should be taken into account in the interpret-
ation of these results. Standardization of the analysis
protocols is needed to make more generalizable
recommendations.
Future research should focus on the construction of
a quantitative model that accurately depicts physio-
logical myocardial blood flow. The different quantitative
models should be compared and validated within a well-
structured standardized CMR perfusion protocol prefer-
ably against a well validated perfusion method to deter-
mine which of the models accurately describes the
perfusion process. Specific cut-off values to distinguish
between normal and ischemic myocardium should be
determined, and CMR protocols should be calibrated
between the different CMR scanners. Visual CMR per-
fusion analysis alone is already highly accurate in the as-
sessment of significant CAD and might also benefit
from standardization of CMR protocols. The included
studies reported results per segment, vessel territory or
per patient. In this study we chose to include all three
groups and report the results separately. However, it
should be noted that a per segment based analysis holds
more anatomical value since CAD often involves only spe-
cific coronary branches and not an entire vessel, affecting
an entire vessel territory. This could have resulted in a
lower diagnostic accuracy for the territory based results.
The per territory analysis however, has a high clinical
value since intervention more likely target the main cor-
onary vessels instead of the secondary branches.
SENSITIVITY (95% CI)
Q = 22.91, df = 9.00, 
p =  0.01
I2 = 60.71 [33.52 − 87.90]
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0.96 [0.82 − 1.00]
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Fig. 6 Forest plot of per patient sensitivity and specificity of both semi-quantitative and quantitative perfusion analysis against anatomical and functional
reference standards. Significant heterogeneity was defined as Q-statistic p < 0.10 and/or I2 > 50%
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Limitations
The main limitations for this meta-analysis is the small
number of studies available regarding either segment,
territory or patient based semi-quantitative or quantita-
tive analysis of SI-curves in the assessment of myocar-
dial perfusion using CMR and the wide variety of CMR
protocols used in these studies. This resulted in a high
degree of heterogeneity and possible bias making inter-
study comparison difficult. Furthermore, there was an
overrepresentation of male patients in the included
studies. This limitation makes the findings less
generalizable for women. We also decided not to in-
clude visual CMR perfusion analysis as the diagnostic
accuracy of this assessment has been assessed in previ-
ous meta-analyses and our aim was to explore the diag-
nostic accuracy of SI-curve based assessment.
Another limitation regarding this meta-analysis are
the wide variety of reference standards used. We de-
cided to pool all reference standards used to provide a
Fig. 8 Deeks’ funnel plots of the studies on per segment (a), per territory (b), and per patient (c) basis. P-value <0.05 indicative of publication bias
or systematic difference between results of larger and smaller studies
Fig. 7 Summary receiver operating curve of the diagnostic
performance of patient based semi-quantitative and quantitative
CMR perfusion analysis
Fig. 9 Deeks’ funnel plots of the subgroup analysis on per territory
basis with anatomical reference standard (a), functional reference
standard (b), semi-quantitative analysis (c), and quantitative analysis
(d). P-value <0.05 indicative of publication bias or systematic differ-
ence between results of larger and smaller studies
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more complete overview of the evidence regarding SI-
curve analysis during CMR perfusion. For our subgroup
analysis we decided to group reference standards on ei-
ther providing anatomical or functional information and
observed a difference in diagnostic accuracy when using
either anatomical or functional reference standards.
We conclude that the reference standard used has
an influence on the diagnostic accuracy of SI-curve
CMR-perfusion analysis and discussed the unclear re-
lationship of both currently used anatomical and
functional reference standards with myocardial flow
and perfusion.
Conclusions
This meta-analysis provides an overview of 23 original
studies reporting on the diagnostic accuracy of semi-
quantitative or quantitative analysis of stress CMR perfu-
sion on a per segment, per territory or per patient basis
for the assessment of significant CAD. Based on our re-
sults we conclude that due to a high degree of inter-study
Fig. 10 Summary of the risk of bias and applicability concerns across the included studies as assessed with QUADAS-2 forms by the reviewers
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heterogeneity the real value of signal intensity curve based
analyses of stress CMR perfusion still remains unclear.
Semi-quantitative analysis showed a higher diagnostic
accuracy for per territory analysis in this meta-analysis,
possibly because it is less complex and less susceptible to
false assumptions during the calculation. However, quanti-
tative analysis still shows the potential to be used for abso-
lute quantification of myocardial blood flow and further
studies should be performed to determine the quantitative
model that best represent true myocardial blood flow. The
standardization and validation of semi-quantitative or
quantitative stress CMR perfusion is necessary before it
can be safely implemented in clinical practice.
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